75N98026F00002

NINDS' DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP): SHAMLOO-SELECTIVE CB2 AGONIST; MRI RESEARCH INC:1186811 [26-000042]

Department of Health and Human Services · MO, United States

This contract has been awarded. Browse open opportunities

View Source

Time Left to Bid

Awarded

AwardedHealthcare & MedicalFederal

Basic information

Reference number: 75N98026F00002
Issuing organization: Department of Health and Human Services · Find award history →
Government level: Federal
Solicitation type: Healthcare & Medical
Title: NINDS' DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP): SHAMLOO-SELECTIVE CB2 AGONIST; MRI RESEARCH INC:1186811 [26-000042]
Source: usaspending
Source ID: CONT_AWD_75N98026F00002_7529_75N98026D00014_7529

Details

Location: MO, United States

Description

NINDS' DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP): SHAMLOO-SELECTIVE CB2 AGONIST; MRI RESEARCH INC:1186811 [26-000042] Awarded to: MRIGLOBAL Sub-agency: National Institutes of Health Contract type: DELIVERY ORDER

Dates

Publication: 2026/08/15 12:00:00 AM UTC
Closing date: 2030/08/14 12:00:00 AM UTC

Estimated value

$1.4M USD

Classification

Normalized category

Healthcare & Medical

Source: usaspending

Last updated 2026-09-02, 1:12:50 a.m.

Data refreshed every 2 hours